SCHEMBL9711384

SCHEMBL9711384

CCCc1c(COc2ccc(C(=O)c3cccc(-c4nnn[nH]4)c3)cc2)ccc(C(C)=O)c1O

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 19/20 0.59
CYSLTR1 Q9Y271 19/20 0.59
CTSD P07339 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9711409 0.92 CYSLTR2 (0.67) CYSLTR2CYSLTR1CTSD
SCHEMBL9711393 0.89 CYSLTR1 (0.59) CYSLTR2CYSLTR1CTSD
SCHEMBL9177390 0.88 CYSLTR2 (0.69) CYSLTR2CYSLTR1CTSD
SCHEMBL9506508 0.87 CYSLTR2 (0.68) CYSLTR2CYSLTR1CTSD
SCHEMBL9506488 0.87 CYSLTR2 (0.68) CYSLTR2CYSLTR1CTSD
SCHEMBL9711392 0.86 CYSLTR2 (0.56) CYSLTR2CYSLTR1CTSD
SCHEMBL9179953 0.85 CYSLTR2 (0.61) CYSLTR2CYSLTR1CTSD
SCHEMBL9711396 0.85 CYSLTR2 (0.66) CYSLTR2CYSLTR1CTSD
SCHEMBL481224 0.85 CYSLTR1 (0.59) CYSLTR2CYSLTR1CTSD
SCHEMBL9177556 0.82 CYSLTR2 (0.61) CYSLTR2CYSLTR1CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0288189-B1 IMPROVEMENTS IN OR RELATING TO LEUKOTRIENE ANTAGONISTS ELI LILLY AND COMPANY (US) 1992-11-11 EP claimed
US-4853398-A ANTIALLERGENS ELI LILLY AND COMPANY (US) 1989-08-01 US claimed
EP-0288189-A1 Improvements in or relating to leukotriene antagonists ELI LILLY AND COMPANY (US) 1988-10-26 EP claimed
EP-0288189-B1 IMPROVEMENTS IN OR RELATING TO LEUKOTRIENE ANTAGONISTS ELI LILLY AND COMPANY (US) 1992-11-11 EP disclosed
US-4853398-A ANTIALLERGENS ELI LILLY AND COMPANY (US) 1989-08-01 US disclosed
EP-0288189-A1 Improvements in or relating to leukotriene antagonists ELI LILLY AND COMPANY (US) 1988-10-26 EP disclosed